{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:17:46Z","timestamp":1794273466032,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27051-4","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T12:32:57Z","timestamp":1763814777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Zinc complex with quinoline-based thiazolyl-hydrazone targeting DNA replication in cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Natalia","family":"Maciejewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0408\u043evana","family":"Ara\u0161kov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Vi\u0161njevac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Stevanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta Barta","family":"Holl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Todorovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"27051_CR1","doi-asserted-by":"publisher","first-page":"2300426","DOI":"10.1002\/ardp.202300426","volume":"357","author":"V \u0106ur\u010di\u0107","year":"2024","unstructured":"\u0106ur\u010di\u0107, V. et al. Quinoline-based thiazolyl\u2010hydrazones target cancer cells through autophagy inhibition. Arch. Pharm. 357, 2300426. https:\/\/doi.org\/10.1002\/ardp.202300426 (2024).","journal-title":"Arch. Pharm."},{"key":"27051_CR2","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.bmc.2014.01.022","volume":"22","author":"D Secci","year":"2014","unstructured":"Secci, D. et al. Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors. Bioorg. Med. Chem. 22, 1680\u20131689 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"27051_CR3","doi-asserted-by":"publisher","first-page":"104088","DOI":"10.1016\/j.bioorg.2020.104088","volume":"102","author":"H Aziz","year":"2020","unstructured":"Aziz, H. et al. Synthesis, characterization, in vitro tissue-nonspecific alkaline phosphatase (TNAP) and intestinal alkaline phosphatase (IAP) Inhibition studies and computational evaluation of novel thiazole derivatives. Bioorg. Chem. 102, 104088. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104088 (2020).","journal-title":"Bioorg. Chem."},{"key":"27051_CR4","doi-asserted-by":"publisher","first-page":"110954","DOI":"10.1016\/j.cbi.2024.110954","volume":"394","author":"LAB Freitas","year":"2024","unstructured":"Freitas, L. A. B. et al. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins. Chem. Biol. Interact. 394, 110954. https:\/\/doi.org\/10.1016\/j.cbi.2024.110954 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"27051_CR5","doi-asserted-by":"publisher","first-page":"2281262","DOI":"10.1080\/14756366.2023.2281262","volume":"38","author":"WAA Fadaly","year":"2023","unstructured":"Fadaly, W. A. A. et al. New pyrazolyl-thiazolidinone\/thiazole derivatives as celecoxib\/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory\/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. J. Enzyme Inhib. Med. Chem. 38, 2281262. https:\/\/doi.org\/10.1080\/14756366.2023.2281262 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"27051_CR6","doi-asserted-by":"publisher","first-page":"103992","DOI":"10.1016\/j.bioorg.2020.103992","volume":"101","author":"AM Omar","year":"2020","unstructured":"Omar, A. M. et al. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual matrix Metalloproteinase-2 and 9 inhibitors: anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects. Bioorg. Chem. 101, 103992. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103992 (2020).","journal-title":"Bioorg. Chem."},{"key":"27051_CR7","doi-asserted-by":"publisher","first-page":"104110","DOI":"10.1016\/j.bioorg.2020.104110","volume":"102","author":"B Sever","year":"2020","unstructured":"Sever, B. et al. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds. Bioorg. Chem. 102, 104110. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104110 (2020).","journal-title":"Bioorg. Chem."},{"key":"27051_CR8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1039\/D2OB02308C","volume":"21","author":"S Dey","year":"2023","unstructured":"Dey, S. et al. Visiblelight-induced ternary electron donor\u2013acceptor complex enabled synthesis of 2-(2-hydrazinyl) thiazole derivatives and the assessment of their antioxidant and antidiabetic therapeutic potential. Org. Biomol. Chem. 21, 1771\u20131779 (2023).","journal-title":"Org. Biomol. Chem."},{"key":"27051_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bioorg.2016.12.011","volume":"70","author":"U Salar","year":"2017","unstructured":"Salar, U. et al. Synthesis, in vitro \u03b2 -glucuronidase inhibitory activity and in Silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles. Bioorg. Chem. 70, 199\u2013209 (2017).","journal-title":"Bioorg. Chem."},{"key":"27051_CR10","doi-asserted-by":"publisher","first-page":"180837","DOI":"10.1098\/rsos.180837","volume":"5","author":"S Hassan","year":"2018","unstructured":"Hassan, S. et al. Synthesis of novel (E)-1-(2-(2-(4(dimethylamino) benzylidene) hydrazinyl)-4-methylthiazol-5-yl)ethanone derivatives as ecto-5\u2032-nucleotidase inhibitors. R Soc. Open. Sci. 5, 180837. https:\/\/doi.org\/10.1098\/rsos.180837 (2018).","journal-title":"R Soc. Open. Sci."},{"key":"27051_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.fct.2017.07.029","volume":"108","author":"G Graser-Loescher","year":"2017","unstructured":"Graser-Loescher, G. et al. Thiosemicarbazone derivatives, Thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with Arabinofuranosylcytosine. Food Chem. Toxicol. 108, 53\u201362 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"27051_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2019.05.044","volume":"177","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E\/eIF4G as multifunctional agents for cancer treatment. E J. Med. Chem. 177, 153\u2013170 (2019).","journal-title":"E J. Med. Chem."},{"key":"27051_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biocel.2019.02.004","volume":"110","author":"S Narayanan","year":"2019","unstructured":"Narayanan, S. et al. Anti-cancer effect of Indanone-based Thiazolyl hydrazone derivative on colon cancer cell lines. Int. J. Biochem. Cell. Biol. 110, 21\u201328 (2019).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"27051_CR14","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.1016\/j.jscs.2022.101488","volume":"26","author":"AM El-Naggar","year":"2022","unstructured":"El-Naggar, A. M., Zidan, A., Elkaeed, E. B., Taghour, M. S. & Badawi, W. A. Design, synthesis and docking studies of new hydrazinyl-thiazole derivatives as anticancer and antimicrobial agents. J. Saudi Chem. Soc. 26, 101488. https:\/\/doi.org\/10.1016\/j.jscs.2022.101488 (2022).","journal-title":"J. Saudi Chem. Soc."},{"key":"27051_CR15","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejmech.2017.10.050","volume":"143","author":"S Carradori","year":"2018","unstructured":"Carradori, S. et al. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. E J. Med. Chem. 143, 1543\u20131552 (2018).","journal-title":"E J. Med. Chem."},{"key":"27051_CR16","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.3390\/molecules27154898","volume":"27","author":"MG Salem","year":"2022","unstructured":"Salem, M. G. et al. Novel 1,3-Thiazole analogues with potent activity against breast cancer: A design, synthesis, in vitro, and in silico study. Molecules 27, 4898. https:\/\/doi.org\/10.3390\/molecules27154898 (2022).","journal-title":"Molecules"},{"key":"27051_CR17","doi-asserted-by":"publisher","first-page":"27355","DOI":"10.1039\/D2RA03624J","volume":"12","author":"AY Khormi","year":"2022","unstructured":"Khormi, A. Y. et al. Novel thiazole derivatives incorporating phenyl sulphonyl moiety as potent BRAFV600E kinase inhibitors targeting melanoma. RSC Adv. 12, 27355\u201327369 (2022).","journal-title":"RSC Adv"},{"key":"27051_CR18","doi-asserted-by":"publisher","first-page":"115976","DOI":"10.1016\/j.bmc.2020.115976","volume":"31","author":"OA El-Khouly","year":"2021","unstructured":"El-Khouly, O. A., Henen, M. A., El-Sayed, M. A. A., Shabaan, M. I. & El-Messery, S. M. Synthesis, anticancer and antimicrobial evaluation of new Benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study. Bioorg. Med. Chem. 31, 115976. https:\/\/doi.org\/10.1016\/j.bmc.2020.115976 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"27051_CR19","doi-asserted-by":"publisher","first-page":"104615","DOI":"10.1016\/j.bioorg.2020.104615","volume":"108","author":"AM El-Naggar","year":"2021","unstructured":"El-Naggar, A. M., El-Hashash, M. A. & Elkaeed, E. B. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors. Bioorg. Chem. 108, 104615 (2021).","journal-title":"Bioorg. Chem."},{"key":"27051_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejmech.2019.05.006","volume":"175","author":"K Piechowska","year":"2019","unstructured":"Piechowska, K. et al. Discovery of tropinone-thiazole derivatives as potent caspase 3\/7 activators, and noncompetitive tyrosinase inhibitors with high antiproliferative activity: rational design, one-pot tricomponent synthesis, and lipophilicity determination. E J. Med. Chem. 175, 162\u2013171 (2019).","journal-title":"E J. Med. Chem."},{"key":"27051_CR21","doi-asserted-by":"publisher","unstructured":"Verma, S., Lal, S., Narang, R. & Sudhakar, K. Quinoline hydrazide\/hydrazone derivatives: Recent insights on antibacterial activity and mechanism of action. ChemMedChem. 18, e202200571. https:\/\/doi.org\/10.1002\/cmdc.202200571 (2023).","DOI":"10.1002\/cmdc.202200571"},{"key":"27051_CR22","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.2174\/0929867325666180309111428","volume":"25","author":"W Cardona-G","year":"2018","unstructured":"Cardona-G, W., Yepes, A. F. & Herrera, R. Hybrid molecules: promising compounds for the development of new treatments against leishmaniasis and Chagas disease. Curr. Med. Chem. 25, 3637\u20133679 (2018).","journal-title":"Curr. Med. Chem."},{"key":"27051_CR23","doi-asserted-by":"publisher","first-page":"104763","DOI":"10.1039\/C6RA23940D","volume":"6","author":"A Bo\u017ei\u0107","year":"2016","unstructured":"Bo\u017ei\u0107, A. et al. Quinoline based mono- and bis-(thio)carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models. RSC Adv. 6, 104763\u2013104781 (2016).","journal-title":"RSC Adv."},{"key":"27051_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2174\/1871520620666200728133017","volume":"21","author":"S Pawar","year":"2021","unstructured":"Pawar, S., Kumar, K., Gupta, M. K. & Rawal, R. K. Synthetic and medicinal perspective of fused-thiazoles as anticancer agents. Anticancer Agents Med. Chem. 21, 1379\u20131402 (2021).","journal-title":"Anticancer Agents Med. Chem."},{"key":"27051_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1021\/acsomega.2c06871","volume":"8","author":"AE Evren","year":"2023","unstructured":"Evren, A. E., Karaduman, A. B., Sa\u011flik, B. N., \u00d6zkay, Y. & Yurtta\u015f, L. Investigation of novel quinoline\u2013thiazole derivatives as antimicrobial agents: in vitro and in silico approaches. ACS Omega. 8, 1410\u20131429 (2023).","journal-title":"ACS Omega"},{"key":"27051_CR26","doi-asserted-by":"publisher","first-page":"215453","DOI":"10.1016\/j.ccr.2023.215453","volume":"499","author":"R Kumar","year":"2024","unstructured":"Kumar, R. et al. Quinoline-based metal complexes: synthesis and applications. Coord. Chem. Rev. 499, 215453. https:\/\/doi.org\/10.1016\/j.ccr.2023.215453 (2024).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ccr.2015.10.003","volume":"308","author":"LMT Frija","year":"2016","unstructured":"Frija, L. M. T., Pombeiro, A. J. L. & Kopylovich, M. N. Coordination chemistry of thiazoles, isothiazoles and thiadiazoles. Coord. Chem. Rev. 308, 32\u201355 (2016).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR28","doi-asserted-by":"publisher","first-page":"116363","DOI":"10.1016\/j.ejmech.2024.116363","volume":"270","author":"A Podolski-Reni\u0107","year":"2024","unstructured":"Podolski-Reni\u0107, A. et al. Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer. E J. Med. Chem. 270, 116363. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116363 (2024).","journal-title":"E J. Med. Chem."},{"key":"27051_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1570180814666171003145227","volume":"15","author":"A Erguc","year":"2018","unstructured":"Erguc, A. et al. Synthesis and biological evaluation of new Quinoline-Based Thiazolyl hydrazone derivatives as potent antifungal and anticancer agents. LDDD 15, 193\u2013202 (2018).","journal-title":"LDDD"},{"key":"27051_CR30","doi-asserted-by":"publisher","first-page":"117162","DOI":"10.1016\/j.poly.2024.117162","volume":"262","author":"JB Ara\u0161kov","year":"2024","unstructured":"Ara\u0161kov, J. B. et al. Structural insights and photophysical properties of mononuclear and pentanuclear Zn(II) acetate complexes with pyridyl-based thiazolyl-hydrazones. Polyhedron 262, 117162. https:\/\/doi.org\/10.1016\/j.poly.2024.117162 (2024).","journal-title":"Polyhedron"},{"key":"27051_CR31","doi-asserted-by":"publisher","first-page":"214088","DOI":"10.1016\/j.ccr.2021.214088","volume":"445","author":"M Pellei","year":"2021","unstructured":"Pellei, M., Del Bello, F., Porchia, M. & Santini, C. Zinc coordination complexes as anticancer agents. Coord. Chem. Rev. 445, 214088. https:\/\/doi.org\/10.1016\/j.ccr.2021.214088 (2021).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR32","doi-asserted-by":"publisher","first-page":"216026","DOI":"10.1016\/j.ccr.2024.216026","volume":"517","author":"M Biswas","year":"2024","unstructured":"Biswas, M., Kanta Choudhury, K., Banerjee, A. & Pathak, R. K. Elevating the discourse on drug delivery: A fresh perspective on the utilization of coordination chemistry-driven metal-drug conjugates. Coord. Chem. Rev. 517, 216026. https:\/\/doi.org\/10.1016\/j.ccr.2024.216026 (2024).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR33","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1039\/D2CE00443G","volume":"24","author":"JB Ara\u0161kov","year":"2022","unstructured":"Ara\u0161kov, J. B. et al. Zn(II) complexes with thiazolyl\u2013hydrazones: structure, intermolecular interactions, photophysical properties, computational study and anticancer activity. CrystEngComm 24, 5194\u20135214 (2022).","journal-title":"CrystEngComm"},{"key":"27051_CR34","doi-asserted-by":"publisher","first-page":"135157","DOI":"10.1016\/j.molstruc.2023.135157","volume":"1281","author":"JB Ara\u0161kov","year":"2023","unstructured":"Ara\u0161kov, J. B. et al. Structural, physicochemical and anticancer study of Zn complexes with pyridyl-based thiazolyl-hydrazones. J. Mol. Struct. 1281, 135157. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135157 (2023).","journal-title":"J. Mol. Struct."},{"key":"27051_CR35","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1080\/00958972.2016.1232404","volume":"69","author":"H Elshaflu","year":"2016","unstructured":"Elshaflu, H. et al. Co(III) complex with (E)-2-(2-(pyridine-2-ylmethylene)hydrazinyl)-4-(4-tolyl)-1,3-thiazole: structure and activity against 2-D and 3-D cancer cell models. J. Coord. Chem. 69, 3354\u20133366 (2016).","journal-title":"J. Coord. Chem."},{"key":"27051_CR36","doi-asserted-by":"publisher","unstructured":"Nakamoto, K. Infrared and Raman spectra of inorganic and coordination compounds. In Handbook of Vibrational Spectroscopy. https:\/\/doi.org\/10.1002\/0470027320.s4104 (Wiley, 2006).","DOI":"10.1002\/0470027320.s4104"},{"key":"27051_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","volume":"252","author":"A Montecucco","year":"2007","unstructured":"Montecucco, A. & Biamonti, G. Cellular response to Etoposide treatment. Cancer Lett. 252, 9\u201318 (2007).","journal-title":"Cancer Lett."},{"key":"27051_CR38","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/S0021-9258(18)69623-1","volume":"234","author":"MT Hakala","year":"1959","unstructured":"Hakala, M. T. Mode of action of 5-bromodeoxyuridine on mammalian cells in culture. J. Biol. Chem. 234, 3072\u20133076 (1959).","journal-title":"J. Biol. Chem."},{"key":"27051_CR39","doi-asserted-by":"publisher","first-page":"100778","DOI":"10.1016\/j.drup.2021.100778","volume":"58","author":"A Valente","year":"2021","unstructured":"Valente, A. et al. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resist. Updat. 58, 100778. https:\/\/doi.org\/10.1016\/j.drup.2021.100778 (2021).","journal-title":"Drug Resist. Updat"},{"key":"27051_CR40","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.drup.2021.100778","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S. Cisplatin: The first metal based anticancer drug. Bioorg. Chem. 88, 102925. https:\/\/doi.org\/10.1016\/j.drup.2021.100778 (2019).","journal-title":"Bioorg. Chem."},{"issue":"5","key":"27051_CR41","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi, L. et al. Systems biology of cisplatin resistance: past, present and future. Cell. Death Dis. 5 (5), e1257. https:\/\/doi.org\/10.1038\/cddis.2013.428 (2014).","journal-title":"Cell. Death Dis."},{"key":"27051_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer. 7, 573\u2013584 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"27051_CR43","doi-asserted-by":"publisher","first-page":"e202218000","DOI":"10.1002\/anie.202218000","volume":"62","author":"G Moreno-Alc\u00e1ntar","year":"2023","unstructured":"Moreno-Alc\u00e1ntar, G., Picchetti, P. & Casini, A. Gold complexes in anticancer therapy: from new design principles to Particle-Based delivery systems. Angew Chem. Int. Ed. Engl. 62, e202218000. https:\/\/doi.org\/10.1002\/anie.202218000 (2023).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"27051_CR44","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.2147\/DDDT.S275007","volume":"14","author":"SY Lee","year":"2020","unstructured":"Lee, S. Y., Kim, C. Y. & Nam, T. G. Ruthenium complexes as anticancer agents: A brief history and perspectives. Drug Des. Devel Ther. 14, 5375\u20135392 (2020).","journal-title":"Drug Des. Devel Ther."},{"key":"27051_CR45","doi-asserted-by":"publisher","first-page":"215579","DOI":"10.1016\/j.ccr.2023.215579","volume":"501","author":"S Abdolmaleki","year":"2024","unstructured":"Abdolmaleki, S., Aliabadi, A. & Khaksar, S. Riding the metal wave: A review of the latest developments in metal-based anticancer agents. Coord. Chem. Rev. 501, 215579. https:\/\/doi.org\/10.1016\/j.ccr.2023.215579 (2024).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR46","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.3390\/molecules25245814","volume":"25","author":"M Porchia","year":"2020","unstructured":"Porchia, M., Pellei, M., Del Bello, F. & Santini, C. Zinc complexes with nitrogen donor ligands as anticancer agents. Molecules 25, 5814. https:\/\/doi.org\/10.3390\/molecules25245814 (2020).","journal-title":"Molecules"},{"issue":"9156285","key":"27051_CR47","first-page":"101155201891562","volume":"2018","author":"SR Lee","year":"2018","unstructured":"Lee, S. R. Critical role of zinc as either an antioxidant or a prooxidant in cellular systems. Oxid. Med. Cell. Longev. 2018 (9156285), 10115520189156285 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"27051_CR48","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.3390\/app10124118","volume":"10","author":"R Leuci","year":"2020","unstructured":"Leuci, R. et al. Importance of biometals as targets in medicinal chemistry: an overview about the role of zinc (II) chelating agents. Appl. Sci. 10, 4118. https:\/\/doi.org\/10.3390\/app10124118 (2020).","journal-title":"Appl. Sci."},{"key":"27051_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s11095-023-03517-w","volume":"40","author":"SR Munnangi","year":"2023","unstructured":"Munnangi, S. R. et al. Drug complexes: perspective from academic research and pharmaceutical market. Pharm. Res. 40, 1519\u20131540 (2023).","journal-title":"Pharm. Res."},{"key":"27051_CR50","doi-asserted-by":"publisher","unstructured":"Nagaraj, K. et al. Synthesis, crystal structure, and computational investigation of zinc\u2013cytosine coordination complex: Insights from molecular docking,HOMO-LUMO, and Appl. Org. Chem. 39, e70215. https:\/\/doi.org\/10.1002\/aoc.70215 (2025).","DOI":"10.1002\/aoc.70215"},{"key":"27051_CR51","doi-asserted-by":"publisher","first-page":"214051","DOI":"10.1016\/j.ccr.2021.214051","volume":"445","author":"NP Juraj","year":"2021","unstructured":"Juraj, N. P. & Kirin, S. I. Inorganic stereochemistry: geometric isomerism in bis-tridentate ligand complexes. Coord. Chem. Rev. 445, 214051. https:\/\/doi.org\/10.1016\/j.ccr.2021.214051 (2021).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR52","doi-asserted-by":"publisher","first-page":"41787","DOI":"10.1021\/acsomega.4c06136","volume":"9","author":"B Halder","year":"2024","unstructured":"Halder, B. et al. Structural characterization, and theoretical analysis of nonconventional bonding in dinuclear Zinc(II) complexes with tridentate schiff bases. ACS Omega. 9, 41787\u201341796 (2024).","journal-title":"ACS Omega"},{"key":"27051_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell. Biol. 16, 2\u20139 (2014).","journal-title":"Nat. Cell. Biol."},{"key":"27051_CR54","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1039\/D3DT00148B","volume":"52","author":"M Jiang","year":"2023","unstructured":"Jiang, M. et al. Development of a zinc(II) 2-pyridinecarboxaldehyde thiosemicarbazone complex with remarkable antitumor and antiangiogenic activities. Dalton Trans. 52, 6029\u20136040 (2023).","journal-title":"Dalton Trans."},{"key":"27051_CR55","doi-asserted-by":"publisher","first-page":"112786","DOI":"10.1016\/j.jinorgbio.2024.112786","volume":"264","author":"Co(II)","year":"2025","unstructured":"Co(II). Cu(II), and Zn(II) thio-bis(benzimidazole) complexes induce apoptosis via mitochondrial pathway. J. Inorg. Biochem. 264, 112786. https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112786 (2025).","journal-title":"J. Inorg. Biochem."},{"key":"27051_CR56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejmech.2015.05.038","volume":"100","author":"KB Huang","year":"2015","unstructured":"Huang, K. B. et al. Isoquinoline derivatives Zn(II)\/Ni(II) complexes: crystal structures, cytotoxicity, and their action mechanism. Eur. J. Med. Chem. 100, 68\u201376 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"27051_CR57","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.3390\/molecules28124876","volume":"28","author":"S Gai","year":"2023","unstructured":"Gai, S. et al. Anticancer activity and mode of action of Cu(II), Zn(II), and Mn(II) complexes with 5-Chloro-2-N-(2-quinolylmethylene)aminophenol. Molecules 28, 4876. https:\/\/doi.org\/10.3390\/molecules28124876 (2023).","journal-title":"Molecules"},{"key":"27051_CR58","doi-asserted-by":"publisher","first-page":"213550","DOI":"10.1016\/j.ccr.2020.213550","volume":"427","author":"N Kumar","year":"2021","unstructured":"Kumar, N., Roopa, Bhalla, V. & Kumar, M. Beyond zinc coordination: bioimaging applications of Zn(II)-complexes. Coord. Chem. Rev. 427, 213550. https:\/\/doi.org\/10.1016\/j.ccr.2020.213550 (2021).","journal-title":"Coord. Chem. Rev."},{"key":"27051_CR59","unstructured":"CrysAlisPRO Oxford Diffraction \/Agilent Technologies UK Ltd, Yarnton, England."},{"key":"27051_CR60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1107\/S1600576715001132","volume":"48","author":"MC Burla","year":"2015","unstructured":"Burla, M. C. et al. Crystal structure determination and refinement via SIR2014. J. Appl. Cryst. 48, 306\u2013309 (2015).","journal-title":"J. Appl. Cryst."},{"key":"27051_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","volume":"71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. C Struct. Chem. 71, 3\u20138 (2015).","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"27051_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1107\/S1600576719014092","volume":"53","author":"CF Macrae","year":"2020","unstructured":"Macrae, C. F. et al. Mercury 4.0: from visualization to analysis, design and prediction. J. Appl. Crystallogr. 53, 226\u2013235 (2020).","journal-title":"J. Appl. Crystallogr."},{"key":"27051_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1107\/S090744490804362X","volume":"65","author":"AL Spek","year":"2009","unstructured":"Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. D Biol. Crystallogr. 65, 148\u2013155 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"27051_CR64","doi-asserted-by":"publisher","first-page":"707366","DOI":"10.3389\/fonc.2021.707366","volume":"11","author":"MA Merlos Rodrigo","year":"2021","unstructured":"Merlos Rodrigo, M. A. et al. Extending the applicability of in ovo and ex ovo chicken chorioallantoic membrane assays to study cytostatic activity in neuroblastoma cells. Front. Oncol. 11, 707366. https:\/\/doi.org\/10.3389\/fonc.2021.707366 (2021).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27051-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:56:31Z","timestamp":1764327391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27051-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42806"}}